| Literature DB >> 22521915 |
Valerie A Morris1, Almira S Punjabi, Robert C Wells, Cristina J Wittkopp, Richard Vart, Michael Lagunoff.
Abstract
The predominant tumor cell of Kaposi's Sarcoma (KS) is the spindle cell, a cell of endothelial origin that expresses markers of lymphatic endothelium. In culture, Kaposi's Sarcoma-associated herpesvirus (KSHV) infection of blood endothelial cells drives expression of lymphatic endothelial cell specific markers, in a process that requires activation of the gp130 receptor and the JAK2/STAT3 and PI3K/AKT signaling pathways. While expression of each of the KSHV major latent genes in endothelial cells failed to increase expression of lymphatic markers, the viral homolog of human IL-6 (vIL-6) was sufficient for induction and requires the JAK2/STAT3 and PI3K/AKT pathways. Therefore, activation of gp130 and downstream signaling by vIL-6 is sufficient to drive blood to lymphatic endothelial cell differentiation. While sufficient, vIL-6 is not necessary for lymphatic reprogramming in the context of viral infection. This indicates that multiple viral genes are involved and suggests a central importance of this pathway to KSHV pathogenesis.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22521915 PMCID： PMC3509939 DOI： 10.1016/j.virol.2012.03.013
Source DB: PubMed Journal: Virology ISSN： 0042-6822 Impact factor: 3.616